Gainers
Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.
Piper Sandler has decided to maintain its Neutral rating of Rigel Pharmaceuticals (NASDAQ:RIGL) and raise its price target from $1.00 to $2.00.
Shares of Rigel Pharmaceuticals are trading up 1.12% over the last 24 hours, at $1.58 per share.
Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.